收藏切换
Determination of crizotinib in non-small cell lung cancer patients plasma by liquid chromatography tandem mass spectrometry
收藏切换
PDF
Qi SHEN, Li LI, Jing LIANG, Min-yu CHENG
Chinese Journal of Clinical Pharmacology | 2025, 41(7) : 1008 - 1012
Less
收藏切换
Chinese Journal of Clinical Pharmacology | 2025, 41(7): 1008-1012
Research Method
Determination of crizotinib in non-small cell lung cancer patients plasma by liquid chromatography tandem mass spectrometry
Full
Qi SHEN, Li LI, Jing LIANG, Min-yu CHENG
Affiliations
  • Depatment of Pharmacy, Zhejiang Hospital, Hangzhou 310013, Zhejiang Province, China
Published: 2025-04-17 doi: 10.13699/j.cnki.1001-6821.2025.07.020
Outline
收藏切换
Objective

To develop a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the determination of crizotinib in human plasma and apply this method to determine its concentration in patients with non-small cell lung cancer after administrating.

Methods

Osimertinib was employed as the internal standard. The plasma samples were performed through protein precipitation with acetonitrile and chromatographed on Agilent Eclipse XDB C18 (2.1 mm×100.0 mm, 3.5 μm), mobile phase was consisted of acetonitrile containing 0.1% formic acid - 10 mmol·L-1 ammonium acetate containing 0.1% formic acid, flow rate was 0.25 mL·min-1, the column temperature was 30 ℃. The whole analytical time was 3 min. The detection was performed by positive ion electrospray ionization in multiple reaction monitoring mode, the quantitative analysis ion pairs were m/z 450.1→259.2 and m/z 500.2→72.1. The specificity, standard curve and lower limit of quantitation, precision and recovery, stability, matrix effect and residual effect of the method were investigated. After full validation, the method was applied to the determination of crizotinib in human plasma.

Results

Good linearity was observed over the concentration range of 10.0-2 500.0 μg·L-1, the calibration curve was y=4.54×10-3x+3.22×10-2 (r=0.992 7). The accuracies were between 97.66%-105.55%. The relative standard deviation of inter-day and intra-day precision were less than 8.49%. The average recoveries and matrix effects were between 80.10%- 86.05% and 95.22%-110.66%.

Conclusion

The LC-MS/MS method is developed which meets the requirements of biological sample analysis and it can quickly, accurately monitor the concentration of crizotinib.

crizotinib  /  liquid chromatography-tandem mass spectrometry  /  non-small cell lung cancer  /  plasma concentration
Qi SHEN, Li LI, Jing LIANG, Min-yu CHENG. Determination of crizotinib in non-small cell lung cancer patients plasma by liquid chromatography tandem mass spectrometry[J]. Chinese Journal of Clinical Pharmacology, 2025 , 41 (7) : 1008 -1012 . DOI: 10.13699/j.cnki.1001-6821.2025.07.020
Year 2025 volume 41 Issue 7
PDF
1
0
Cite this Article
BibTeX
Article Info
doi: 10.13699/j.cnki.1001-6821.2025.07.020
  • Receive Date:2024-10-30
  • Online Date:2026-08-04
  • Published:2025-04-17
Article Data
Affiliations
History
  • Received:2024-10-30
Funding
Affiliations
    Depatment of Pharmacy, Zhejiang Hospital, Hangzhou 310013, Zhejiang Province, China
References
Share
https://castjournals.cast.org.cn/joweb/zglcylxzz/EN/10.13699/j.cnki.1001-6821.2025.07.020
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT